Immucor GTI Diagnostics, Inc

Retham Technologies LLC, based in Milwaukee, WI, is a pioneering company dedicated to revolutionizing the diagnosis and management of Heparin-induced Thrombocytopenia (HIT). Their mission is to develop a technically-simple in vitro diagnostic (IVD) test called HITDx, which aims to provide accurate and timely diagnosis of HIT, ultimately reducing morbidity, saving lives, and lowering the cost of care for HIT-suspected patients. Established in 2017, Retham Technologies is committed to translating recent discoveries into a life-saving IVD assay that offers earlier and more precise in-hospital diagnosis of HIT. With the goal of improving patient outcomes, their innovative HITDx test is expected to facilitate timely and appropriate therapy, leading to better overall results for individuals affected by this serious adverse reaction to the blood thinner heparin.Generated from the website

Capri Communities, under the umbrella of Tarantino & Co LLC in Waukesha, specializes in crafting living spaces tailored to various life stages. Their offerings range from dynamic Independent Living to cutting-edge Assisted Living and Memory Care services. At Capri, residents are embraced as family, receiving personalized care and support in a warm and welcoming environment. Their commitment to creating enriching experiences for individuals at every stage of life sets them apart in the senior living industry. Generated from their website's infomation

Vector Surgical, based in Waukesha, WI, is a global leader in tissue orientation systems for cancer surgery. Their innovative devices, including the MarginMarker sterile ink kit and CorrectClips radiographic markers, are embraced by cancer experts worldwide for providing accurate and secure delineation of specimen margins. With a focus on eliminating errors in margin interpretation, Vector Surgical's products have been praised by physicians and surgeons for their precision and effectiveness in ensuring proper pathologic specimen readings. The company's commitment to medical research and partnerships underscores their dedication to improving outcomes for patients undergoing breast, head and neck, pancreatic, cutaneous, and soft tissue sarcoma cancer surgeries.Generated from the website